The 2012 Sacramento Area Regional Technology Alliance (SARTA) Med Tech Showcase on Tuesday, June 5, will feature a keynote address by Siemens Healthcare North America CEO Dr. Gregory Sorensen and presentation of the Claire Pomeroy Award for Innovation in Medical Technology.

“This is the largest medical technology gathering in the Sacramento region and we’re excited about this year’s program. Anyone with an interest in our med tech sector should be there,” said Cary Adams, chair of SARTA’s MedStart program.

With an anticipated attendance of 300, the full-day program at the Woodlake Hotel will also highlight specific new technologies recently adopted by the Sacramento region’s four major health providers, how and why they were selected, and lessons learned for others seeking to sell new technologies to similar customers. Speakers at this session include Gregory Graves, M.D., Sutter Health; Cindy Holst, M.H.A., Chief Strategy Officer at Dignity Health, Sacramento-San Joaquin Region; W. Douglas Boyd, M.D., UC Davis Health System; and Andrew Klonecke, M.D., Kaiser Permanente.

Sorensen will speak about Siemens’ commitment to making healthcare faster, better and more cost-effective, especially in its work in medical imaging, therapy systems, laboratory diagnostics and healthcare information technology. He has served as CEO of Siemens Healthcare North America since June 2011, and was previously professor of Radiology and Health Sciences & Technology at Harvard Medical School; a faculty member of the Harvard-MIT Division of Health Sciences and Technology; and co-director of the A.A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital.

Also to be discussed at the event is the issue of access to capital for startup and early-stage medical device companies. Four leading venture capital investors will share their perspectives on the changing investment landscape in a panel discussion moderated by Pete Bernadoni, Partner, Wavepoint Ventures: Douglas Crawford, Associate Director, QB3; John Maroney, General Partner, Delphi Ventures; Ned Scheetz, Managing Director, Aphelion Capital; and William G. Gerber, Investment Partner, Bay City Capital.

Three additional and concurrent afternoon sessions will highlight current Sacramento region med tech strengths, including molecular imaging, telehealth and regenerative cures.

SARTA in April announced that the number of Sacramento region med tech companies now totals 113, up 10 percent over 2011. The SARTA MedStart Progress Report 2012 identified 21 new medical device and bioscience companies, and indicates that regional med tech employment currently totals approximately 4,700.

Med Tech Showcase tickets and more information are available at http://www.sarta.org/Med-Tech-Showcase-2012.html.

MedStart strives to build a thriving bioscience industry in the Sacramento region and its mission is to catalyze that growth. MedStart’s programs include a CEO Forum, Telehealth Forum, Regenerative Medicine Forum, its showcase and mixer, and bi-monthly workshops. Planning continues on the Medical Device Design Innovation Center (MeDDIC), a prototyping facility to accelerate innovation. For more information visit: http://www.sarta.org/medstart.html .